Literature DB >> 7583581

Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma.

Y J Geng1, J Holm, S Nygren, M Bruzelius, S Stemme, G K Hansson.   

Abstract

Scavenger receptors mediate internalization of modified lipoproteins and foam cell transformation of monocyte-derived cytokines. We investigated macrophage scavenger receptor (MSR) expression in monocyte-macrophages from human peripheral blood and in atherosclerotic lesions and analyzed its relationship to T lymphocytes and immunoregulatory cytokines by immunohistochemistry and polymerase chain reaction (PCR). Antibodies specific for the two MSR isoforms were generated by immunizing rabbits with isoform-specific synthetic peptides conjugated to keyhole limpet hemocyanin. In human atherosclerotic plaques, these antibodies stained macrophages and foam cells in a pattern that corresponded to the distribution of the macrophage marker CD68. CD3-positive T cells and alpha-actin-positive smooth muscle cells exhibited no reactivity to the anti-MSR antibodies. The frequency of cells stained with antibodies to MSR type I was equal to that of cells stained for type II, suggesting that most macrophages coexpress both isoforms. Reverse transcription (RT)-PCR analysis confirmed that both MSR isoforms were expressed in all plaques examined. There was, however, a tendency toward a lower immunohistochemical staining intensity for MSR type I and a decreased number of lipid-rich foam cells in T cell-rich areas. The mRNAs for interleukin-2 and interferon-gamma, two major products of activated T cells, were detected by RT-PCR in all plaques tested. This indicates that activation of T lymphocytes occurs in atherosclerotic plaques. Since interferon-gamma downregulates MSR expression, these observations suggest a potential mechanism for local regulation of MSR expression in the atherosclerotic plaque.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583581     DOI: 10.1161/01.atv.15.11.1995

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.

Authors:  Nicole M Iverson; Nicole M Plourde; Sarah M Sparks; Jinzhong Wang; Ekta N Patel; Pratik S Shah; Daniel R Lewis; Kyle R Zablocki; Gary B Nackman; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2011-08-03       Impact factor: 12.479

Review 2.  Immunology of atherosclerosis: the promise of mouse models.

Authors:  A H Lichtman; M Cybulsky; F W Luscinskas
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

3.  The effect of gamma-interferon to inhibit macrophage-high density lipoprotein interactions is reversed by 15-deoxy-delta12,14-prostaglandin J2.

Authors:  S H Zuckerman; C Panousis; J Mizrahi; G Evans
Journal:  Lipids       Date:  2000-11       Impact factor: 1.880

Review 4.  Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson.

Authors:  Yong-Jian Geng; Lena Jonasson
Journal:  Vascul Pharmacol       Date:  2011-11-20       Impact factor: 5.773

5.  Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.

Authors:  X Zhou; G Paulsson; S Stemme; G K Hansson
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

6.  Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.

Authors:  X Zhou; S Stemme; G K Hansson
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

7.  Peroxisome proliferator-activated receptor alpha,gamma coagonist LY465608 inhibits macrophage activation and atherosclerosis in apolipoprotein E knockout mice.

Authors:  Steven H Zuckerman; Raymond F Kauffman; Glenn F Evans
Journal:  Lipids       Date:  2002-05       Impact factor: 1.880

Review 8.  T-lymphocytes and monocytes in atherogenesis.

Authors:  G Schmitz; A S Herr; G Rothe
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

9.  Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}/JAK/STAT1 signaling is critical for the expression of PTN in macrophages.

Authors:  Fuqiang Li; Fang Tian; Lai Wang; Ian K Williamson; Behrooz G Sharifi; Prediman K Shah
Journal:  FASEB J       Date:  2009-11-16       Impact factor: 5.191

10.  Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1.

Authors:  Shu-Meng Cheng; Shih-Ping Yang; Ling-Jun Ho; Tien-Ping Tsao; Deh-Ming Chang; Jenn-Haung Lai
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.